Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
FGFR4
Name:
fibroblast growth factor receptor 4
Location:
05q35.2
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT06258408 | A Phase 1 Study of BB102 in Participants With Advanced Solid Tumors | View | |
| NCT01100840 | A Retrospective Study of Biomarkers in Non-Small Cell Lung Cancer | View | |
| NCT01752920 | Phase 12 Study of Derazantinib ARQ 087 in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations | View | |
| NCT02325739 | FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression | View | |
| NCT02476019 | A Safety Tolerability PK and PD Study of Once Weekly ISIS-FGFR4RX SC in Obese Patients | View | |
| NCT02834780 | Phase 1 Study to Evaluate the Safety Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma | View | |
| NCT04699643 | FGFR4 Inhibitor EVER4010001 in Combination With PD-1 Inhibitor Pembrolizumab in Patients With Advanced Solid Tumors | View | |
| NCT05498519 | A First-in-Human Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor | View | |
| NCT02272998 | Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes FGFR1 FGFR2 FGFR3 FGFR4 RET KIT | View | |
| NCT02508467 | A Phase 1 Study of Fisogatinib BLU-554 in Patients With Hepatocellular Carcinoma | View |